Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Duaklir Genuair for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)

Drug (Brand / Generic)

Duaklir Genuair (aclidinium bromide/formoterol fumarate)

Company / Licensee

Almirall/AstraZeneca

Therapy Class

Anticholinergic drug

Current Indication

Chronic obstructive pulmonary disease (COPD)

Market Sector

Respiratory

Development Status

Approved in Europe
Expand

Go Top